Sun Pharmaceutical Industries Share Price Today - Live Blog for October 14, 2025

Sun Pharmaceutical Industries Ltd shares saw a -0.15% decrease, reaching a current market price of ₹1,652.10. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 38.5100, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd experienced a -0.00% downturn in its share price, and it's currently trading at ₹1,653.95. This situation is generating interest among value investors who are evaluating the stock's potential.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.09% in its share price, and it currently trades at ₹1,654.00 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd share price has declined by -0.32%, and it's currently trading at ₹1,655.75. The stock maintains a PE of 38.5100, while the industry PE is 35.0675, prompting discussions about its valuation.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.39% surge in its share price and is presently trading at ₹1,661.70. The increased investor interest is driving this surge.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.03%, a development that warrants careful analysis. Presently trading at ₹1,653.75, investors are assessing whether this presents an opportunity or a risk.

Sun Pharmaceutical Industries Ltd witnessed a -0.02% drop in its share price and is currently trading at ₹1,653.30. With the stock's PE at 38.5100 and the industry PE at 35.0675, investors are weighing their options.

After a -0.27% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,652.30. The stock has a PE ratio of 38.5100, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd experienced a substantial 0.06% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,656.75, making it an appealing option for investors.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.26%, reaching the current market price of ₹1,655.75. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.29% drop, and it's now trading at ₹1,650.40 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The share price of Sun Pharmaceutical Industries Ltd experienced an impressive 0.11% upswing and is currently trading at ₹1,655.20, indicating strong market sentiment.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.21%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,653.20, and market participants are assessing the implications. The stock has a PE ratio of 38.5100, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.21% decline, and it currently trades at ₹1,653.20 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.21% decline and is currently trading at ₹1,653.20 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Sun Pharmaceutical Industries Ltd shares experienced a -0.21% reduction, with the current market price at ₹1,653.20. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.31% increase and currently trading at ₹1,656.60 per share. This upward trajectory is turning heads in the market.

Sun Pharmaceutical Industries Ltd witnessed a -0.22% drop in its share price and is currently trading at ₹1,647.65. With the stock's PE at 38.5100 and the industry PE at 35.0675, investors are weighing their options.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.16% decline and is currently trading at ₹1,652.20 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

With a -0.17% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,656.30. The stock is currently trading at a PE of 38.5100, while the industry PE is 35.0675, prompting investors to assess its value proposition.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.06%, and as of now, it's trading at ₹1,659.75 per share. This upward trajectory is attracting keen interest from investors.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.06%, and it is currently trading at ₹1,659.75. Additionally, the stock maintains a PE ratio of 38.5100, while the industry PE is 35.0675.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.05% decline, and it currently trades at ₹1,658.75 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.05%, signalling a challenging period. Currently trading at ₹1,658.75, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.00% increase and currently trading at ₹1,659.35 per share. This upward trajectory is turning heads in the market.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.03%, reaching the current market price of ₹1,659.75. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.09% decline, and it currently trades at ₹1,661.70 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Sun Pharmaceutical Industries Ltd share price has declined by -0.27%, and it's currently trading at ₹1,663.90. The stock maintains a PE of 38.5100, while the industry PE is 35.0675, prompting discussions about its valuation.